EPSRC

UK's NICE Reverses Course on Immunocore's Kimmtrak for Advanced Uveal Melanoma

Epsilogen Launches Phase Ib IgE Antibody Trial in Advanced Ovarian Cancer

Novartis Pens $2.9B Deal With PTC Therapeutics for Huntington's Disease Drug

Final FDA Guidance Lays Path for Drugmakers to Establish Circulating Tumor DNA as Trial Endpoint

Merck, Moderna Vax Trial Starts Enrolling Lung Cancer Patients at McGill University Health Center

Senti Biosciences Announces $37.6M PIPE Financing, Reports Early Data From Phase I CAR-NK Trial